Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...
Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...
The Medtronic MiniMedâ„¢ 780G system consists of the following ... is intended for use with the MiniMedâ„¢ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of ...
Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...
By analyzing data from Medtronic diabetes monitoring devices (insulin pumps and glucose monitors), IBM's artificial intelligence computer Watson can predict a low blood sugar problem up to three ...
Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...
That person already used an insulin pump from Medtronic and is now using the glucose monitoring system from Medtronic as well. And after about one week, I find the results impressive. The ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
Medtronic's 780g insulin pump automates much ... blood glucose is a major advancement over the point-in-time blood glucose meters that typically provided two to four blood glucose readings in ...